Schedule 13G ownership disclosure
UROGEN PHARMA LTD
Security class unavailable · CUSIP: M96088105
Event date: 2017-05-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-037493
- Form type
- SC 13G
- Filer
- ProQuest Investments IV, L.P.
- CIK
- CIK 1431818
- Filed
- Jul 20, 2017
- Reporting period
- May 09, 2017
- Description
- Schedule 13G beneficial ownership